Topic:

Use of MARIA® for Foods to Compare the Allergen Content of Early Introduction Food (EIF) Brands

Description:

InBio’s has further developed its multiplex technology, MARIA® for Foods, to simultaneously measure up to 17 major food allergens from a single sample. This state-of-the-art technology was recently used to compare specific food allergen levels in EIF brands, as reported at the AAAAI annual meeting. The study demonstrated significant variability in the allergen concentration and dose in EIF from nine manufacturers, when tested for 17 major allergens.

Learning Objectives:

• Understand the applications of MARIA® for Foods for measuring specific food allergens
• Discuss details, data, and impact of the EIF study.
• Understand how Indoor Biotechnologies’ molecular approach to food allergy can improve the quality of EIF and other therapeutic products for food allergy.

When:

Wednesday, March 3rd, 2021 from 11am to 12pm EST.

Over the last 5 years with InBio, I have helped customers across Europe get the most out of our products and services to support their business activities. In my new role as European Business Manager, along with our team of experts in the UK, I will be capitalising on the new facilities and techniques we invested in last year. This will allow us to broaden the range of services that we can offer our customers.

These include a new Environmental Testing Suite, designed in accordance with AHAM, AC-1 standards and our proprietary viral testing capabilities, both of which will support product development and efficacy claims for a broad range of home and personal care products.

As the new leader of the UK company, I look forward to the challenges 2021 will bring, and will endeavour to deliver the high level of excellence that our customers have come to expect from Indoor Biotechnologies over the years. Please feel free to contact me directly.

InBio scientists will be presenting seven oral presentations and posters at the virtual meeting, including a late breaking abstract on large variability in allergen concentrations in commercial early allergen introduction foods. Find details on InBio^®‘s 2021 AAAAI content below, and a full list here.

LATE BREAKING Abstract Title: Simultaneous Quantification of Major Allergens in Early Introduction Foods using a Fluorescent Multiplex Array
Type: Poster Session
Poster Number: L25
Session Date / Time: This is a published session from 02/26/2021 through 03/01/2021.

Abstract Title: Human IgE Monoclonal Antibodies to Inhaled and Food Allergens: Unique Probes for Clinical Investigation
Type: Poster Session
Poster Number: 456
Session Date / Time: This is a published session from 02/26/2021 through 03/01/2021.

Abstract Title: Production of Recombinant Cannabis Sativa Allergen, Can s 3 and Development of a Two-site Immunoassay
Type: Poster Session
Poster Number: 460
Session Date / Time: This is a published session from 02/26/2021 through 03/01/2021.

Abstract Title: Stability of Cockroach Allergens Versus Non-allergens
Type: Poster Session
Poster Number: 260
Session Date / Time: This is a published session from 02/26/2021 through 03/01/2021.

Saturday, February 27^th, 2021

Abstract Title: SARS-CoV-2 full length spike protein for COVID-19 vaccine development and diagnostic testing
Type: Oral Abstract Session
Title: The Best of Basic and Clinical Immunology
Poster Number: 484
Session Date / Time: 02/27/2021, 5:10pm – 6:25pm

Abstract Title: Natural Human IgE Monoclonal Antibody Defines a Unique Epitope on Der p 2
Type: Oral Abstract Session
Title: Cells and Molecules of Allergic Inflammation
Poster Number: 490
Session Date / Time: 02/27/2021, 5:10pm – 6:25pm

Sunday, February 28^th, 2021

Abstract Title: The Major Cat Allergen, Fel d 1, Is a Viable Target for CRISPR Gene Editing
Type: Oral Abstract Session
Title: Immune Regulation of the Allergic Response: Novel Insights
Poster Number: 554
Session Date / Time: 02/28/2021, 5:10pm – 6:25pm